Nasdaq:US$17.27 (-0.51) | HKEX:HK$27.30 (-0.90) | AIM:£2.64 (-0.09)
Search Result
Previous Article   |   Next Article
Scientific Publications | 4 Jun 2021

ASCO 2021: A Multicenter Open-Label Phase 1 Study Evaluating the Safety and Tolerability of HMPL-306 in Patients with Locally Advanced or Metastatic Solid Tumors with IDH Mutations